Common Equity: The sum of all common equity items.
Zhengye Biotechnology Holding Limited (ZYBT) had Common Equity of $50.97M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$28.12M |
|
$34.44M |
|
$42.32M |
|
$70.44M |
|
$18.82M |
|
$0.66M |
|
$0.66M |
|
$19.48M |
|
|
Common Equity |
$50.97M |
$47.73M |
|
$50.97M |
|
47.39M |
|
| Cash Flow Statement Financials | |
$-1.95M |
|
$-0.09M |
|
$5.91M |
|
$2.60M |
|
$6.37M |
|
$3.77M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|